 | Inozyme Pharma, Inc. | |||
| NMS : INZY || Location: United States | ||||
$4.4+0.01 (+0.23%) |
0.74 M | 4.4 - 4.62 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.583 M |
| March 15, 2024 | 2.383 M |
| Feb. 29, 2024 | 2.319 M |
| Feb. 15, 2024 | 2.395 M |
| Jan. 31, 2024 | 2.868 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.32 | -0.33 | -1.57% |
| 09/30/2023 | -0.32 | -0.29 | 10.11% |
| 06/30/2023 | -0.44 | -0.35 | 20.76% |
| 03/31/2023 | -0.45 | -0.40 | 12.07% |
| 12/31/2022 | -0.46 | -0.42 | 8.83% |
INZY Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 61.772M | Shares Float | 34.134M |
| Short Float | 2.583M | Market Cap | 271.80M |
| Institution ownership | 92.95% | Insider ownership | 0.657% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.37 | Forward EPS | -1.60 |